Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 490

1.
2.

In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.

Lowe DB, Shearer MH, Tarbox JA, Kang HS, Jumper CA, Bright RK, Kennedy RC.

Virology. 2005 Feb 5;332(1):28-37.

4.

Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.

Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC.

J Virol. 2010 Jan;84(2):883-93. doi: 10.1128/JVI.01512-09. Epub 2009 Nov 4.

6.
7.
8.

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.

Aldrich JF, Shearer MH, Lowe DB, Winn RE, Jumper CA, Kennedy RC, Bright RK.

Cancer Immunol Immunother. 2013 Feb;62(2):371-82. doi: 10.1007/s00262-012-1338-x. Epub 2012 Aug 25.

PMID:
22926061
9.

CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.

Aldrich JF, Lowe DB, Shearer MH, Winn RE, Jumper CA, Bright RK, Kennedy RC.

J Virol. 2011 Jul;85(14):7216-24. doi: 10.1128/JVI.00543-11. Epub 2011 May 18.

11.

Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.

Lowe DB, Shearer MH, Aldrich JF, Winn RE, Jumper CA, Kennedy RC.

J Virol. 2010 Oct;84(19):10121-30. doi: 10.1128/JVI.01095-10. Epub 2010 Jul 28.

12.
14.

Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.

Newmaster RS, Mylin LM, Fu TM, Tevethia SS.

Virology. 1998 May 10;244(2):427-41.

15.

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.

Fallarino F, Grohmann U, Bianchi R, Vacca C, Fioretti MC, Puccetti P.

J Immunol. 2000 Nov 15;165(10):5495-501.

16.

Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice.

Mauch C, Grimm C, Meckel S, Wands JR, Blum HE, Roggendorf M, Geissler M.

Vaccine. 2001 Oct 12;20(1-2):170-80.

PMID:
11567762
17.

Nucleic acid vaccination against virally induced tumors.

Bright RK, Shearer MH, Kennedy RC.

Ann N Y Acad Sci. 1995 Nov 27;772:241-51.

PMID:
8546399
18.

Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.

Kennedy RC, Shearer MH, Lowe DB, Jumper CA, Chiriva-Internati M, Bright RK.

Cancer Immunol Immunother. 2004 Nov;53(11):987-94. Epub 2004 May 19.

PMID:
15156293
20.

Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.

Bright RK, Shearer MH, Pass HI, Kennedy RC.

Dev Biol Stand. 1998;94:341-53.

PMID:
9776255
Items per page

Supplemental Content

Write to the Help Desk